Sigma Planning Corp Increases Position in The Clorox Company $CLX

Sigma Planning Corp increased its stake in shares of The Clorox Company (NYSE:CLX) by 55.0% during the first quarter, Holdings Channel reports. The institutional investor owned 29,650 shares of the company’s stock after acquiring an additional 10,522 shares during the period. Sigma Planning Corp’s holdings in Clorox were worth $3,073,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Wilkins Investment Counsel Inc. grew its holdings in Clorox by 250.6% in the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after purchasing an additional 39,360 shares during the last quarter. Morningstar Investment Management LLC increased its position in shares of Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock valued at $6,297,000 after buying an additional 35,506 shares in the last quarter. National Pension Service raised its stake in shares of Clorox by 68.9% during the 4th quarter. National Pension Service now owns 27,537 shares of the company’s stock worth $2,777,000 after buying an additional 11,233 shares during the last quarter. Swiss Life Asset Management Ltd boosted its position in shares of Clorox by 221.4% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock worth $10,656,000 after buying an additional 59,533 shares in the last quarter. Finally, Birch Hill Investment Advisors LLC acquired a new stake in Clorox in the 4th quarter valued at about $22,103,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of CLX opened at $98.67 on Friday. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03. The company’s 50 day simple moving average is $94.51 and its 200 day simple moving average is $104.07. The company has a market capitalization of $11.93 billion, a price-to-earnings ratio of 16.02, a PEG ratio of 0.46 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the previous year, the company earned $1.45 EPS. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts predict that The Clorox Company will post 5.52 EPS for the current year.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the subject of a number of research reports. Barclays cut their target price on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. TD Cowen upped their target price on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. JPMorgan Chase & Co. dropped their price target on Clorox from $95.00 to $92.00 and set an “underweight” rating for the company in a research report on Thursday. Finally, Wells Fargo & Company cut their price target on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a report on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and an average target price of $103.47.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.